Robert C. Bast

Zhen Zhang, Hong Zhang, Robert C. Bast, 2000, Proceedings of the IEEE-INNS-ENNS International Joint Conference on Neural Networks. IJCNN 2000. Neural Computing: New Challenges and Perspectives for the New Millennium.

Nomenclature: Systeme Internationale (SI) Units

Donald W Kufe, Robert C. Bast, James F. Holland, 2003 .

Rethinking ovarian cancer: recommendations for improving outcomes

Kenneth P. Nephew, James D. Brenton, Robert C. Bast, 2011, Nature Reviews Cancer.

A Multiplexable, Microfluidic Platform for the Rapid Quantitation of a Biomarker Panel for Early Ovarian Cancer Detection at the Point-of-Care

Robert C. Bast, John T. McDevitt, Jorge Wong, 2014, Cancer Prevention Research.

Translational Crossroads for Biomarkers

Robert C. Bast, Mark A. Rubin, Robert Veltri, 2005, Clinical Cancer Research.

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

Sudhir Srivastava, David F. Ransohoff, Martin W. McIntosh, 2011, Cancer Prevention Research.

The Rehabilitation Specialist

Donald W Kufe, Raphael E. Pollock, Robert C. Bast, 2003 .

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.

Thomas J. Smith, Robert C. Bast, Daniel F. Hayes, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor Necrosis Factor α as an Autocrine and Paracrine Growth Factor for Ovarian Cancer: Monokine Induction of Tumor Cell Proliferation and Tumor Necrosis Factor α Expression

Robert C. Bast, R. Bast, A. Berchuck, 1993 .

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer

Catharine M. Sturgeon, Robert C. Bast, Per Hyltoft Petersen, 2015, International Journal of Gynecologic Cancer.

Reproducibility of SELDI Spectra Across Time and Laboratories

Jeffrey S. Morris, Kevin R. Coombes, Robert C. Bast, 2011, Cancer informatics.

The biology of ovarian cancer: new opportunities for translation

Robert C. Bast, Gordon B. Mills, G. Mills, 2009, Nature Reviews Cancer.

Combined use of biomarkers for detection of ovarian cancer in high-risk women

Robert C. Bast, Yinhua Yu, Weiwei Feng, 2010, Tumor Biology.

Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

Robert C. Bast, Keith A. Baggerly, Gordon B. Mills, 2004, Clinical Cancer Research.

Ovarian cancer: screening, treatment, and followup.

Robert C. Bast, Robert W. Makuch, Alice S. Whittemore, 1995, NIH consensus statement.

NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms

Yan Wang, Zhen Lu, Robert C. Bast, 2015, Oncotarget.

HER2-targeting Antibodies Modulate the Cyclin-dependent Kinase Inhibitor p27Kip1 via Multiple Signaling Pathways

Robert C. Bast, R. Bast, X. Le, 2005, Cell cycle.